Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: verma k. Nat Immunol. 2021 May;22(5):620-626. doi: 10.1038/s41590-021-00902-8. Epub 2021 Mar 5. Nat Immunol. 2021. PMID: 33674800 Free PMC article.
Unique features and clinical importance of acute alloreactive immune responses.
Inman CF, Eldershaw SA, Croudace JE, Davies NJ, Sharma-Oates A, Rai T, Pearce H, Sirovica M, Chan YLT, Verma K, Zuo J, Nagra S, Kinsella F, Nunnick J, Amel-Kashipaz R, Craddock C, Malladi R, Moss P. Inman CF, et al. Among authors: verma k. JCI Insight. 2018 May 17;3(10):e97219. doi: 10.1172/jci.insight.97219. eCollection 2018 May 17. JCI Insight. 2018. PMID: 29769441 Free PMC article.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: verma k. Nat Immunol. 2021 Jul;22(7):928. doi: 10.1038/s41590-021-00957-7. Nat Immunol. 2021. PMID: 34017126 Free PMC article. No abstract available.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S. Dowell AC, et al. Among authors: verma k. Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937928 Free PMC article.
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
Parry H, Bruton R, Roberts T, McIlroy G, Damery S, Sylla P, Dowell AC, Tut G, Lancaster T, Bone D, Willett B, Logan N, Scott S, Hulme S, Jadir A, Amin U, Nicol S, Stephens C, Faustini S, Al-Taei S, Richter A, Blakeway D, Verma K, Margielewska-Davies S, Pearce H, Pratt G, Zuo J, Paneesha S, Moss P. Parry H, et al. Among authors: verma k. Cancer Cell. 2022 Jun 13;40(6):584-586. doi: 10.1016/j.ccell.2022.05.001. Epub 2022 May 6. Cancer Cell. 2022. PMID: 35588735 Free PMC article. No abstract available.
1,273 results